报告质量差,经济评估与实用试验中的缺失数据比例高:一个跨部门调查
Yu Xin1, Ruomeng Song2, Jun Hao3,4,5
1Department of Science and Technology, West China Hospital, Sichuan University, Chengdu, China.
BMC medical research methodology
|March 6, 2025
概括
在实用临床试验 (pRCT) 经济评估中缺少数据是常见的,并且报告不充分. 这影响了研究结论和决策的可靠性.
科学领域:
- 卫生经济学 卫生经济学
- 临床试验方法论 临床试验方法论
- 数据完整性 数据完整性
背景情况:
- 数据完整性在临床试验中至关重要,特别是在经济评估中.
- 实用随机对照试验 (pRCT) 越来越多地用于经济评估.
- 关于基于pRCT的经济评估中缺失的数据数量,处理和报告的数据有限.
研究的目的:
- 调查缺失数据的数量和报告质量.
- 评估缺少数据的处理方法.
- 与实用临床试验一起评估经济评估.
主要方法:
- 2010年至2022年间发表的研究的横截面调查.
- 从PubMed和OVID数据库中提取的数据.
- 缺少数据特征和处理方法的描述性分析.
主要成果:
- 152项研究符合纳入标准;超过50%报告缺失数据比例.
- 高整体失踪率 (30.22%) 和数据和效应的中位数比例.
- 只有36.84%的人对缺失的数据进行了敏感性分析;报告的机制或方法很少.
结论:
- 报告不足和pRCT经济评估中缺失数据的高比例降低了可靠性.
- 报告不良做法可能导致误导性结论和决策.
- 需要提高报告经济评估中缺少数据的标准.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
417
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
111
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
111
Bias in Epidemiological Studies
120
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
120
Bias
3.7K
Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...
3.7K
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Regression Toward the Mean
6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Blinding
2.3K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.3K
